These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


287 related items for PubMed ID: 17055733

  • 1. Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism.
    Sagi Y, Mandel S, Amit T, Youdim MB.
    Neurobiol Dis; 2007 Jan; 25(1):35-44. PubMed ID: 17055733
    [Abstract] [Full Text] [Related]

  • 2. Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway.
    Mandel SA, Sagi Y, Amit T.
    Neurochem Res; 2007 Oct; 32(10):1694-9. PubMed ID: 17701352
    [Abstract] [Full Text] [Related]

  • 3. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 4. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
    Muñoz A, Rey P, Guerra MJ, Mendez-Alvarez E, Soto-Otero R, Labandeira-Garcia JL.
    Neuropharmacology; 2006 Jul; 51(1):112-20. PubMed ID: 16678218
    [Abstract] [Full Text] [Related]

  • 5. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo.
    Tomac A, Lindqvist E, Lin LF, Ogren SO, Young D, Hoffer BJ, Olson L.
    Nature; 1995 Jan 26; 373(6512):335-9. PubMed ID: 7830766
    [Abstract] [Full Text] [Related]

  • 6. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Jan 26; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 7. Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism.
    Reznichenko L, Kalfon L, Amit T, Youdim MB, Mandel SA.
    Neurodegener Dis; 2010 Jan 26; 7(4):219-31. PubMed ID: 20197647
    [Abstract] [Full Text] [Related]

  • 8. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
    Chung YC, Kim SR, Jin BK.
    J Immunol; 2010 Jul 15; 185(2):1230-7. PubMed ID: 20566832
    [Abstract] [Full Text] [Related]

  • 9. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.
    Du Y, Li X, Yang D, Zhang X, Chen S, Huang K, Le W.
    Exp Biol Med (Maywood); 2008 Jul 15; 233(7):881-90. PubMed ID: 18445767
    [Abstract] [Full Text] [Related]

  • 10. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease.
    Zhao Q, Gao J, Li W, Cai D.
    Brain Res; 2010 Jul 30; 1346():224-36. PubMed ID: 20478277
    [Abstract] [Full Text] [Related]

  • 11. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB, Fridkin M, Zheng H.
    Mech Ageing Dev; 2005 Feb 30; 126(2):317-26. PubMed ID: 15621213
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons.
    McKinley ET, Baranowski TC, Blavo DO, Cato C, Doan TN, Rubinstein AL.
    Brain Res Mol Brain Res; 2005 Nov 30; 141(2):128-37. PubMed ID: 16209898
    [Abstract] [Full Text] [Related]

  • 13. Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    D'Astous M, Mendez P, Morissette M, Garcia-Segura LM, Di Paolo T.
    Mol Pharmacol; 2006 Apr 30; 69(4):1492-8. PubMed ID: 16434614
    [Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated transduction with human glial cell line-derived neurotrophic factor gene prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopamine depletion in striatum of mouse brain.
    Kojima H, Abiru Y, Sakajiri K, Watabe K, Ohishi N, Takamori M, Hatanaka H, Yagi K.
    Biochem Biophys Res Commun; 1997 Sep 18; 238(2):569-73. PubMed ID: 9299553
    [Abstract] [Full Text] [Related]

  • 15. Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.
    O'Neill MJ, Murray TK, Whalley K, Ward MA, Hicks CA, Woodhouse S, Osborne DJ, Skolnick P.
    Eur J Pharmacol; 2004 Feb 20; 486(2):163-74. PubMed ID: 14975705
    [Abstract] [Full Text] [Related]

  • 16. Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivo.
    Bar-Am O, Yogev-Falach M, Amit T, Sagi Y, Youdim MB.
    J Neurochem; 2004 Jun 20; 89(5):1119-25. PubMed ID: 15147504
    [Abstract] [Full Text] [Related]

  • 17. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
    Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):170-9. PubMed ID: 15790541
    [Abstract] [Full Text] [Related]

  • 18. Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease.
    Kurkowska-Jastrzebska I, Litwin T, Joniec I, Ciesielska A, Przybyłkowski A, Członkowski A, Członkowska A.
    Int Immunopharmacol; 2004 Oct 24; 4(10-11):1307-18. PubMed ID: 15313429
    [Abstract] [Full Text] [Related]

  • 19. Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Chen LW, Hu HJ, Liu HL, Yung KK, Chan YS.
    Neuroscience; 2004 Oct 24; 126(4):941-53. PubMed ID: 15207328
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective rather than neurorescue or neurorestorative effect of selegiline against MPTP-induced dopaminergic toxicity.
    Wu WR, Zhu XZ, Guan HJ, Wang RG, Ji XQ.
    Zhongguo Yao Li Xue Bao; 1999 Feb 24; 20(2):146-50. PubMed ID: 10437162
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.